Search
AtriCure Inc
ATRCAdd to Watchlist
28.120USD
-0.030-0.11%
Close 05/15, 16:00（ET）Quotes delayed by 15 min
1.42BMarket Cap
LossP/E TTM
More Details of AtriCure Inc Company
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.
AtriCure Inc Info
Ticker SymbolATRC
Company nameAtriCure Inc
IPO dateAug 05, 2005
CEOCarrel (Michael H)
Number of employees1300
Security typeOrdinary Share
Fiscal year-endAug 05
Address7555 Innovation Way
CityMASON
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code45040
Phone15137554100
Websitehttps://www.atricure.com
Ticker SymbolATRC
IPO dateAug 05, 2005
CEOCarrel (Michael H)
Company Executives of AtriCure Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Michael H. (Mike) Carrel, CPA
Mr. Michael H. (Mike) Carrel, CPA
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
796.06K
+12.20%
Mr. Salvatore Privitera, J.D.
Mr. Salvatore Privitera, J.D.
Chief Technical Officer
Chief Technical Officer
158.05K
+20.54%
Mr. Robert S. (Bob) White
Mr. Robert S. (Bob) White
Independent Chairman of the Board
Independent Chairman of the Board
122.17K
+24.56%
Mr. Justin J. Noznesky
Mr. Justin J. Noznesky
Chief Marketing and Strategy Officer
Chief Marketing and Strategy Officer
106.40K
+25.94%
Dr. Vinayak Doraiswamy, Ph.D.
Dr. Vinayak Doraiswamy, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
96.88K
+25.81%
Mr. Karl S. Dahlquist, J.D.
Mr. Karl S. Dahlquist, J.D.
Chief Legal Officer
Chief Legal Officer
96.05K
+28.63%
Mr. Sven A. Wehrwein, CPA
Mr. Sven A. Wehrwein, CPA
Independent Director
Independent Director
34.37K
--
Ms. Regina E. (Reggie) Groves
Ms. Regina E. (Reggie) Groves
Independent Director
Independent Director
33.72K
--
Ms. Deborah H. (Deb) Telman
Ms. Deborah H. (Deb) Telman
Independent Director
Independent Director
22.18K
--
Mr. Shlomo Nachman
Mr. Shlomo Nachman
Independent Director
Independent Director
18.51K
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Michael H. (Mike) Carrel, CPA
Mr. Michael H. (Mike) Carrel, CPA
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
796.06K
+12.20%
Mr. Salvatore Privitera, J.D.
Mr. Salvatore Privitera, J.D.
Chief Technical Officer
Chief Technical Officer
158.05K
+20.54%
Mr. Robert S. (Bob) White
Mr. Robert S. (Bob) White
Independent Chairman of the Board
Independent Chairman of the Board
122.17K
+24.56%
Mr. Justin J. Noznesky
Mr. Justin J. Noznesky
Chief Marketing and Strategy Officer
Chief Marketing and Strategy Officer
106.40K
+25.94%
Dr. Vinayak Doraiswamy, Ph.D.
Dr. Vinayak Doraiswamy, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
96.88K
+25.81%
Mr. Karl S. Dahlquist, J.D.
Mr. Karl S. Dahlquist, J.D.
Chief Legal Officer
Chief Legal Officer
96.05K
+28.63%
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Appendage Management-United states
178.13M
33.32%
Open Ablation - United states
143.85M
26.91%
Pain management
81.92M
15.33%
Appendage management -International
42.05M
7.87%
Open ablation -International
41.04M
7.68%
Other
47.54M
8.89%
By RegionUSD
Name
Revenue
Proportion
United States
435.37M
81.45%
Europe
61.49M
11.50%
Asia
30.72M
5.75%
Other international
6.94M
1.30%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Appendage Management-United states
178.13M
33.32%
Open Ablation - United states
143.85M
26.91%
Pain management
81.92M
15.33%
Appendage management -International
42.05M
7.87%
Open ablation -International
41.04M
7.68%
Other
47.54M
8.89%
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Wellington Management Company, LLP
7.74%
AllianceBernstein L.P.
7.04%
BlackRock Institutional Trust Company, N.A.
6.85%
Hood River Capital Management LLC
6.11%
Vanguard Portfolio Management, LLC
5.34%
Other
66.92%
Shareholders
Shareholders
Proportion
Wellington Management Company, LLP
7.74%
AllianceBernstein L.P.
7.04%
BlackRock Institutional Trust Company, N.A.
6.85%
Hood River Capital Management LLC
6.11%
Vanguard Portfolio Management, LLC
5.34%
Other
66.92%
Shareholder Types
Shareholders
Proportion
Investment Advisor
49.74%
Investment Advisor/Hedge Fund
39.33%
Hedge Fund
7.45%
Individual Investor
4.05%
Research Firm
1.63%
Pension Fund
0.68%
Bank and Trust
0.64%
Sovereign Wealth Fund
0.42%
Insurance Company
0.03%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
505
48.18M
95.14%
-7.01M
2025Q4
492
49.59M
116.79%
-102.71K
2025Q3
520
49.71M
119.25%
-705.98K
2025Q2
524
50.25M
121.23%
-1.55M
2025Q1
527
51.69M
113.33%
-4.41M
2024Q4
514
47.94M
122.38%
-3.05M
2024Q3
505
52.36M
125.18%
-207.95K
2024Q2
494
52.59M
116.92%
+1.07M
2024Q1
500
51.55M
109.93%
-1.63M
2023Q4
498
48.92M
106.78%
+1.54M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Wellington Management Company, LLP
3.92M
7.87%
-374.10K
-8.72%
Dec 31, 2025
AllianceBernstein L.P.
3.56M
7.15%
+4.99K
+0.14%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
3.47M
6.96%
+56.37K
+1.65%
Dec 31, 2025
Hood River Capital Management LLC
3.10M
6.22%
+51.02K
+1.68%
Dec 31, 2025
Nomura Investment Management Business Trust
2.04M
4.09%
-250.67K
-10.95%
Dec 31, 2025
State Street Investment Management (US)
1.24M
2.49%
-21.92K
-1.73%
Dec 31, 2025
Geode Capital Management, L.L.C.
1.19M
2.39%
+443.00
+0.04%
Dec 31, 2025
First Light Asset Management, LLC
1.18M
2.36%
+285.08K
+32.02%
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
State Street SPDR S&P Health Care Equipment ETF
1.75%
Harbor Human Capital Factor US Small Cap ETF
0.7%
Invesco NASDAQ Future Gen 200 ETF
0.5%
First Trust Small Cap Growth AlphaDEX Fund
0.44%
Fidelity Enhanced Small Cap ETF
0.33%
Amplify Etho Climate Leadership U.S. ETF
0.3%
Franklin US Small Cap Multifactor Index ETF
0.25%
JPMorgan Fundamental Data Science Small Core ETF
0.24%
iShares U.S. Medical Devices ETF
0.2%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.17%
View more
State Street SPDR S&P Health Care Equipment ETF
Proportion1.75%
Harbor Human Capital Factor US Small Cap ETF
Proportion0.7%
Invesco NASDAQ Future Gen 200 ETF
Proportion0.5%
First Trust Small Cap Growth AlphaDEX Fund
Proportion0.44%
Fidelity Enhanced Small Cap ETF
Proportion0.33%
Amplify Etho Climate Leadership U.S. ETF
Proportion0.3%
Franklin US Small Cap Multifactor Index ETF
Proportion0.25%
JPMorgan Fundamental Data Science Small Core ETF
Proportion0.24%
iShares U.S. Medical Devices ETF
Proportion0.2%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proportion0.17%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
